EUVIMEDEUVIMED entdecken
Crossref

CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma

Natalie L Demirjian, Bino A Varghese, Steven Y Cen, Darryl H Hwang, Manju Aron, Imran Siddiqui, Brandon K K Fields, Xiaomeng Lei, Felix Y Yap, Marielena Rivas, Sharath S Reddy, Haris Zahoor und 5 weitere

European Radiology · 2022-04 · 32 (4) · 2552-2563

DOI: 10.1007/s00330-021-08344-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, online erschienen am 10.11.2021. Verfasst von Natalie L Demirjian und 16 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: NCI NIH HHS, american cancer society, southern california clinical and translational science institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate the utility of CT-based radiomics signatures in discriminating low-grade (grades 1-2) clear cell renal cell carcinomas (ccRCC) from high-grade (grades 3-4) and low TNM stage (stages I-II) ccRCC from high TNM stage (stages III-IV). METHODS: A total of 587 subjects (mean age 60.2 years ± 12.2; range 22-88.7 years) with ccRCC were included. A total of 255 tumors were high grade and 153 were high stage. For each subject, one dominant tumor was delineated as the region of interest (ROI). Our institutional radiomics pipeline was then used to extract 2824 radiomics features across 12 texture families from the manually segmented volumes of interest. Separate iterations of the machine learning models using all extracted features (full model) as well as only a subset of previously identified robust metrics (robust model) were developed. Variable of importance (VOI) analysis was performed using the out-of-bag Gini index to identify the top 10 radiomics metrics driving each classifier. Model performance was reported using area under the receiver operating curve (AUC). RESULTS: The highest AUC to distinguish between low- and high-grade ccRCC was 0.70 (95% CI 0.62-0.78) and the highest AUC to distinguish between low- and high-stage ccRCC was 0.80 (95% CI 0.74-0.86). Comparable AUCs of 0.73 (95% CI 0.65-0.8) and 0.77 (95% CI 0.7-0.84) were reported using the robust model for grade and stage classification, respectively. VOI analysis revealed the importance of neighborhood operation-based methods, including GLCM, GLDM, and GLRLM, in driving the performance of the robust models for both grade and stage classification. CONCLUSION: Post-validation, CT-based radiomics signatures may prove to be useful tools to assess ccRCC grade and stage and could potentially add to current prognostic models. Multiphase CT-based radiomics signatures have potential to serve as a non-invasive stratification schema for distinguishing between low- and high-grade as well as low- and high-stage ccRCC. KEY POINTS: • Radiomics signatures derived from clinical multiphase CT images were able to stratify low- from high-grade ccRCC, with an AUC of 0.70 (95% CI 0.62-0.78). • Radiomics signatures derived from multiphase CT images yielded discriminative power to stratify low from high TNM stage in ccRCC, with an AUC of 0.80 (95% CI 0.74-0.86). • Models created using only robust radiomics features achieved comparable AUCs of 0.73 (95% CI 0.65-0.80) and 0.77 (95% CI 0.70-0.84) to the model with all radiomics features in classifying ccRCC grade and stage, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAdultAgedAged, 80 and overArea Under CurveHumansMachine LearningMiddle AgedRetrospective StudiesTomography, X-Ray ComputedYoung Adult

Stichwörter der Autor:innen

CarcinomaMachine learningNeoplasm gradingNeoplasm staging, radiomicsRenal cell

Autor:innen und Institutionen

  • College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA.
  • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Scripps Mercy Hospital San Diego, San Diego, CA, USA.
  • Radiology Associates of San Luis Obispo, Atascadero, CA, USA.
  • Department of Urology, Yale New Haven Hospital, New Haven, CT, USA.

Förderung

  • NCI NIH HHS
  • american cancer society
  • southern california clinical and translational science institute

Zitieren

APA

Demirjian, N. L., Varghese, B. A., Cen, S. Y., Hwang, D. H., Aron, M., Siddiqui, I., Fields, B. K. K., Lei, X., Yap, F. Y., Rivas, M., Reddy, S. S., Zahoor, H., Liu, D. H., Desai, M., Rhie, S. K., Gill, I. S., & Duddalwar, V. (2022). CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. European Radiology, 32(4), 2552-2563. https://doi.org/10.1007/s00330-021-08344-4

Vancouver

Demirjian NL, Varghese BA, Cen SY, Hwang DH, Aron M, Siddiqui I, et al. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. European Radiology. 2022;32(4):2552-2563. doi:10.1007/s00330-021-08344-4

BibTeX
@article{Demirjian2022,
  author = {Demirjian, Natalie L and Varghese, Bino A and Cen, Steven Y and Hwang, Darryl H and Aron, Manju and Siddiqui, Imran and Fields, Brandon K K and Lei, Xiaomeng and Yap, Felix Y and Rivas, Marielena and Reddy, Sharath S and Zahoor, Haris and Liu, Derek H and Desai, Mihir and Rhie, Suhn K and Gill, Inderbir S and Duddalwar, Vinay},
  title = {CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma},
  journal = {European Radiology},
  year = {2022},
  volume = {32},
  number = {4},
  pages = {2552--2563},
  doi = {10.1007/s00330-021-08344-4}
}
Kostenlos starten →